[Unfavorable interactions of drugs after their combined use in cardiovascular pathology].

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Терапевтический архив

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 345514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adverse Reactions to β-Adrenergic Receptor Blocking Drugs: A Report from the Boston Collaborative Drug Surveillance Program

  2012cited by this paper
• Problems encountered in long-term treatment with anticoagulants.

  2009cited by this paper
• Clinical and electrophysiological effects of intravenous quinidine in man.

  1977cited by this paper
• Present state of alpha and beta adrenergic drugs III. Beta blocking agents.

  1977cited by this paper
• Beta blockers in the treatment of acute arrhythmias [proceedings].

  1977cited by this paper
• [Problems of combined therapy with cardiac glycosides and anti-anginal drugs (author's transl)].

  1977cited by this paper
• Effect of cholestyramine on digoxin absorption and excretion in man.

  1977cited by this paper
• Treatment of chronic ventricular arrhythmias [proceedings].

  1977cited by this paper
• Quinidine-induced ventricular flutter and fibrillation without digitalis therapy.

  1976cited by this paper
• Drugs in the management of hypertension. Part I.

  1976cited by this paper
• Drugs in the management of hypertension. Part II.

  1976cited by this paper
• Spironolactone. I. Disposition and metabolism

  1976cited by this paper
• The rational use of diuretics in the treatment of arterial hypertension.

  1976cited by this paper
• The clinical pharmacology of beta-adrenoceptor-blocking drugs.

  1976cited by this paper
• Examinations with oxygen-aparing analgesics in anginous patients.

  1976cited by this paper
• [Antihypertensive treatment and anesthetic risk].

  1976cited by this paper
• Adverse reactions to beta-blocking drugs: a review.

  1976cited by this paper
• Vasodilator Administration in the Presence of Beta‐Adrenergic Blockade

  1976cited by this paper
• [Pharmacokinetics and drug interactions of digitalis glycosides].

  1976cited by this paper
• Effect of selected drugs on arterial pressure response to upright posture.

  1976cited by this paper
• Spironolactone. II. Bioavailability

  1976cited by this paper
• Clinical aspects of digitalis treatment.

  1976cited by this paper
• Antiarrhythmic drugs for ischemic heart disease.

  1976cited by this paper
• Patient acceptability of propranolol and the occurence of side effects.

  1976cited by this paper
• Techniques for the study of the biochemical basis of drug action.

  1976cited by this paper
• [Drug interactions].

  1976cited by this paper
• Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.

  1976cited by this paper
• Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.

  1976cited by this paper
• [Drug interactions in cardiovascular therapy].

  1975cited by this paper
• Cardiovascular Drug Interactions

  1975cited by this paper
• Increasing the inotropic effect and toxic dose of digitalis by the administration of antikaliuretic drugs--further evidence for a cardiac effect of diuretic agents.

  1975cited by this paper
• Drug interactions in cardiovascular therapy.

  1975cited by this paper
• Clinical studies of Norpace (Part I).

  1975cited by this paper
• Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.

  1974cited by this paper
• Beta-adrenergic receptor blocking drugs in hypertension.

  1974cited by this paper
• Some cardiovascular effects of a beta 2-receptor stimulant (Salbutamol).

  1974cited by this paper
• Influence of serum digoxin concentration measurements on frequency of digitoxicity

  1974cited by this paper
• Individualization of dosage of antiarrhythmic drugs.

  1974cited by this paper
• Correlation of serum magnesium levels and cardiac digitalis intoxication.

  1974cited by this paper
• Beta-blocking therapy: Propranolol.

  1974cited by this paper
• Inhibition of diphenylhydantoin metabolism by chloramphenicol.

  1973cited by this paper
• Hemodynamic interaction of procainamide and lidocaine after experimental myocardial infarction.

  1973cited by this paper
• Clinical findings in patients with hypercalcaemia. A preliminary investigation based on biochemical screening.

  1973cited by this paper
• Altered absorption of digoxin in patients given propantheline and metoclopramide.

  1973cited by this paper
• Total body potassium changes with prolonged diuretic therapy.

  1973cited by this paper
• Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program.

  1973cited by this paper
• Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.

  1973cited by this paper
• Efficacy of phenytoin in the management of ventricular arrhythmias induced by hypokalaemia.

  1973cited by this paper
• Sensitivity to digitalis drugs in acute myocardial infarction.

  1972cited by this paper
• [Clinical and experimental determination of the digitalization level].

  1972cited by this paper
• Drug therapy. Serum drug concentrations as therapeutic guides.

  1972cited by this paper
• Combined treatment of atrial fibrillation with quinidine and beta-blockers.

  1972cited by this paper
• Contribution of Quantitative Assay Technics to the Understanding of the Clinical Pharmacology of Digitalis

  1972cited by this paper
• Pharmacokinetics of procainamide.

  1972cited by this paper
• Interactions between digitoxin and other drugs in man.

  1972cited by this paper
• Beta‐Receptor Blockade and Myocardial Effects of Cardiac Glycosides

  1971cited by this paper
• Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man

  1971cited by this paper
• BIOCHEMICAL AND GENETIC FACTORS REGULATING DILANTIN METABOLISM IN MAN *

  1971cited by this paper
• Infectious mononucleosis.

  1971cited by this paper
• The role of magnesium in digitalis toxicity.

  1971cited by this paper
• Pharmacokinetic of procainamide in man.

  1971cited by this paper
• The electrophysiologic effects of antiarrhythmic drugs.

  1971cited by this paper
• Treatment and prevention of cardiac arrhythmias with propranolol and quinidine.

  1971cited by this paper
• INTERACTIONS BETWEEN DIGITOXIN AND OTHER DRUGS IN VITRO AND IN VIVO

  1971cited by this paper
• Digitalis intoxication. A prospective clinical study with serum level correlations.

  1971cited by this paper
• Measurement of Serum Digitalis Glycosides Clinical Implications

  1971cited by this paper
• Relationship of Plasma Digitoxin and Digoxin to Cardiac Response Following Intravenous Digitalization in Man

  1970cited by this paper
• Acute diphenylhydantoin intoxication following halothane anesthesia.

  1970cited by this paper
• Quinidine excretion in aciduria and alkaluria.

  1969cited by this paper
• Effects of Propranolol and Isosorbide Dinitrate on Exercise Performance and Adrenergic Activity in Patients with Angina Pectoris

  1969cited by this paper
• Clinical pharmacology of furosemide and ethacrynic acid.

  1969cited by this paper
• Inhibition of drug metabolism by chloramphenicol.

  1969cited by this paper
• Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic Effects

  1968cited by this paper
• Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy

  1966cited by this paper
• Dicoumarol-induced diphenylhydantoin intoxication.

  1966cited by this paper

• No citing papers are available for this paper.